Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference38 articles.
1. Recent advances in the management of cholangiocarcinomas;Vauthey;Semin Liver Dis,1994
2. Changing international trends in mortality rates for liver, biliary and pancreatic tumours;Khan;J Hepatol,2002
3. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States;Patel;Hepatology,2001
4. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998;Taylor-Robinson;Gut,2001
5. Cholangiocarcinoma;Khan;Lancet,2005
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role and Function of Receptor Tyrosine Kinases in BRAF Mutant Cancers;Receptors;2024-03-04
2. Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids;Biomedicines;2023-12-30
3. Synergistic effect of sorafenib with Platycladus orientalis (L) leaf extract on cervical cancer;Bioscience Journal;2023-01-27
4. Sorafenib tosylate novel drug delivery systems: Implications of nanotechnology in both approved and unapproved indications;OpenNano;2022-11
5. Ibuprofen and diclofenac differentially affect cell viability, apoptosis and morphology changes of human cholangiocarcinoma cell lines;Journal of Taibah University Medical Sciences;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3